Novo Targets Hair Loss Market in Direct-to-Consumer Push
Product·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Novo Nordisk A/S is eyeing the hair-loss market as the maker of Ozempic seeks to expand its direct-to-consumer pharmaceuticals business.
This move marks a significant shift for the company as it looks to diversify its product offerings beyond diabetes treatments.
Novo Nordisk
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Novo Nordisk A/S is eyeing the hair-loss market as the maker of Ozempic seeks to expand its direct-to-consumer pharmaceuticals business.”
Bloomberg — Ozempic Maker Novo Looks to Target Hair Loss in Consumer Push